1. Home
  2. PCRX vs HTBI Comparison

PCRX vs HTBI Comparison

Compare PCRX & HTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • HTBI
  • Stock Information
  • Founded
  • PCRX 2006
  • HTBI 1926
  • Country
  • PCRX United States
  • HTBI United States
  • Employees
  • PCRX N/A
  • HTBI N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • HTBI Savings Institutions
  • Sector
  • PCRX Health Care
  • HTBI Finance
  • Exchange
  • PCRX Nasdaq
  • HTBI Nasdaq
  • Market Cap
  • PCRX 604.7M
  • HTBI 641.9M
  • IPO Year
  • PCRX 2011
  • HTBI 2012
  • Fundamental
  • Price
  • PCRX $20.61
  • HTBI $31.60
  • Analyst Decision
  • PCRX Buy
  • HTBI Buy
  • Analyst Count
  • PCRX 10
  • HTBI 4
  • Target Price
  • PCRX $26.60
  • HTBI $39.00
  • AVG Volume (30 Days)
  • PCRX 754.5K
  • HTBI 33.4K
  • Earning Date
  • PCRX 02-27-2025
  • HTBI 01-22-2025
  • Dividend Yield
  • PCRX N/A
  • HTBI 1.52%
  • EPS Growth
  • PCRX N/A
  • HTBI 14.18
  • EPS
  • PCRX N/A
  • HTBI 3.52
  • Revenue
  • PCRX $694,957,000.00
  • HTBI $187,440,000.00
  • Revenue This Year
  • PCRX $4.94
  • HTBI N/A
  • Revenue Next Year
  • PCRX N/A
  • HTBI N/A
  • P/E Ratio
  • PCRX N/A
  • HTBI $8.98
  • Revenue Growth
  • PCRX 4.40
  • HTBI 2.84
  • 52 Week Low
  • PCRX $11.16
  • HTBI $23.55
  • 52 Week High
  • PCRX $34.01
  • HTBI $38.99
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 65.95
  • HTBI 28.44
  • Support Level
  • PCRX $18.18
  • HTBI $32.80
  • Resistance Level
  • PCRX $19.45
  • HTBI $33.74
  • Average True Range (ATR)
  • PCRX 0.77
  • HTBI 0.83
  • MACD
  • PCRX -0.04
  • HTBI -0.19
  • Stochastic Oscillator
  • PCRX 91.70
  • HTBI 5.85

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About HTBI HomeTrust Bancshares Inc.

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products.

Share on Social Networks: